000187465 001__ 187465
000187465 005__ 20190416220718.0
000187465 0247_ $$2doi$$a10.2217/cpr.13.40
000187465 037__ $$aARTICLE
000187465 245__ $$aImplantable devices: the future of blood monitoring? (Editorial)
000187465 269__ $$a2013
000187465 260__ $$c2013
000187465 336__ $$aJournal Articles
000187465 520__ $$aImplantable devices can be developed for the simultaneous monitoring of a specific group of key metabolites, identified by more complex techniques, such as mass spectroscopy- or nuclear magnetic -based analysis.. Since there is a strong correlation between metabolite concentration in the blood and in the extracellular space, often it is more convenient to locate the implant into the subcutaneous tissues, to avoid coagulation problems and long-term pharmacological therapies.
000187465 700__ $$0240269$$g167918$$aDe Micheli, Giovanni
000187465 700__ $$0242418$$g176461$$aBoero, Cristina
000187465 700__ $$aCarrara, Sandro$$g182237$$0242413
000187465 773__ $$j10$$tFSG Future Medicine Clinical Practice$$k4$$q385-388
000187465 8564_ $$uhttps://infoscience.epfl.ch/record/187465/files/cpr%20E13%202E40.pdf$$zn/a$$s1232142$$yn/a
000187465 909C0 $$xU11140$$0252283$$pLSI1
000187465 909CO $$particle$$ooai:infoscience.tind.io:187465$$qGLOBAL_SET$$pSTI$$pIC
000187465 917Z8 $$x112915
000187465 917Z8 $$x112915
000187465 917Z8 $$x112915
000187465 937__ $$aEPFL-ARTICLE-187465
000187465 973__ $$rREVIEWED$$sPUBLISHED$$aEPFL
000187465 980__ $$aARTICLE